65 related articles for article (PubMed ID: 27010496)
1. CYP gene expressions in obesity-associated metabolic syndrome.
Tabur S; Oztuzcu S; Oguz E; Demiryürek S; Dagli H; Alasehirli B; Ozkaya M; Demiryürek AT
Obes Res Clin Pract; 2016; 10(6):719-723. PubMed ID: 27010496
[TBL] [Abstract][Full Text] [Related]
2. Association of Rho/Rho-kinase gene polymorphisms and expressions with obesity-related metabolic syndrome.
Tabur S; Oztuzcu S; Oguz E; Korkmaz H; Eroglu S; Ozkaya M; Demiryürek AT
Eur Rev Med Pharmacol Sci; 2015; 19(9):1680-8. PubMed ID: 26004609
[TBL] [Abstract][Full Text] [Related]
3. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
Sarikaya D; Bilgen C; Kamataki T; Topcu Z
Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
[TBL] [Abstract][Full Text] [Related]
4. Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome.
Tabur S; Oztuzcu S; Duzen IV; Eraydin A; Eroglu S; Ozkaya M; Demiryürek AT
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1388-97. PubMed ID: 25967713
[TBL] [Abstract][Full Text] [Related]
5. Detection of cytochrome P450-2A6, -3A5 and -4B1 with real-time polymerase chain reaction in prostate tissue.
Zencir S; Alptekin D; Celiktas M; Canturk P; Colak D; Caner V; Luleyap UH; Topcu Z
Z Naturforsch C J Biosci; 2008; 63(9-10):780-4. PubMed ID: 19040121
[TBL] [Abstract][Full Text] [Related]
6. [Expression of cytochrome P450 related genes in oral submucous fibrosis tissue].
Xie H; Liu J; Ling TY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Dec; 47(12):743-7. PubMed ID: 23328101
[TBL] [Abstract][Full Text] [Related]
7. The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes.
Fava C; Montagnana M; Danese E; Sjögren M; Almgren P; Guidi GC; Hedblad B; Engström G; Minuz P; Melander O
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):31-6. PubMed ID: 22484021
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 3A mRNA expression along goat and rat gastrointestinal tracts.
Mureithi D; Darwish WS; Ikenaka Y; Kanja L; Ishizuka M
Jpn J Vet Res; 2012 Nov; 60(4):205-10. PubMed ID: 23304981
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
10. The role of cytochrome b5 structural domains in interaction with cytochromes P450.
Sergeev GV; Gilep AA; Usanov SA
Biochemistry (Mosc); 2014 May; 79(5):406-16. PubMed ID: 24954591
[TBL] [Abstract][Full Text] [Related]
11. Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Jin SJ; Kim HS; Lim HS
Pharmacogenet Genomics; 2015 Dec; 25(12):595-608. PubMed ID: 26367500
[TBL] [Abstract][Full Text] [Related]
12. Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes.
Shimizu M; Sawaya R; Kishimoto I; Yamazaki H
Clin Chim Acta; 2015 Feb; 441():71-4. PubMed ID: 25532948
[TBL] [Abstract][Full Text] [Related]
13. CYP4F2 and CYP3A5 gene polymorphisms and lung cancer in Chinese Han population.
He R; Li M; Li A; Dang W; Yang T; Li J; Zhang N; Jin T; Chen M
Clin Exp Med; 2020 Aug; 20(3):461-468. PubMed ID: 32350633
[TBL] [Abstract][Full Text] [Related]
14. Expression alterations of cytochromes P4501A1, 2E1, and 3A, and their receptors AhR and PXR caused by 1-octyl-3-methylimidazolium chloride in mouse mammary carcinoma cells.
Li X; Ma J; Jing C; Wang J
Chemosphere; 2013 Nov; 93(10):2488-92. PubMed ID: 24094773
[TBL] [Abstract][Full Text] [Related]
15. Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome.
Tabur S; Oztuzcu S; Oguz E; Demiryürek S; Dagli H; Alasehirli B; Ozkaya M; Demiryürek AT
Endocrine; 2016 Aug; 53(2):465-70. PubMed ID: 26956845
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
17. Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity.
Rao PS; Kumar S
Alcohol Clin Exp Res; 2016 Jan; 40(1):73-82. PubMed ID: 26727525
[TBL] [Abstract][Full Text] [Related]
18. Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6.
Hu H; Yu T; Arpiainen S; Lang MA; Hakkola J; Abu-Bakar A
Toxicol Appl Pharmacol; 2015 Nov; 289(1):30-9. PubMed ID: 26343999
[TBL] [Abstract][Full Text] [Related]
19. Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Zhou J; Wen Q; Li SF; Zhang YF; Gao N; Tian X; Fang Y; Gao J; Cui MZ; He XP; Jia LJ; Jin H; Qiao HL
Oncotarget; 2016 Aug; 7(31):50612-50623. PubMed ID: 27203676
[TBL] [Abstract][Full Text] [Related]
20. Revealing the contribution of Cytochrome P450 to salt-sensitive hypertension using DNA microarray.
Kuang ZM; Huang ZJ; Li Y; Yang GP; Liu ML; Yuan H
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3148-56. PubMed ID: 24338455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
